U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1361 - 1370 of 1679 results

Status:
Possibly Marketed Outside US
First approved in 2015
Source:
Tonic Gel with horse chestnut and leech extract Horse Force by Zeldis-farma, Ooo
Source URL:

Class:
PROTEIN

Status:
Possibly Marketed Outside US
Source:
Nuwiq by Octapharma Pharmazeutika Produktionsges M B H [Canada]
Source URL:

Class:
PROTEIN

Status:
Possibly Marketed Outside US
Source:
Le-Blen FGF Serum by LeBlen Beauty Inc.
Source URL:
First approved in 2014
Source:
Dr. Cellapy SR Premium Solution by GM Holdings Co., Ltd
Source URL:

Class:
PROTEIN

Status:
Possibly Marketed Outside US
Source:
NCT02234869: Phase 4 Interventional Withdrawn Relapsing Multiple Sclerosis
(2014)
Source URL:

Class:
PROTEIN

Status:
Possibly Marketed Outside US
Source:
NCT00555087: Phase 4 Interventional Unknown status Erectile Dysfunction
(2007)
Source URL:

Class:
PROTEIN

Showing 1361 - 1370 of 1679 results